Levofloxacin — Drug Intelligence | 21 EU Trials

Filter these 21 trials by condition, phase, country and more.

Open in Search →

21 Registered trials

9 Recruiting

3 Completed trials

14 Sponsors

16 Countries

Phase III

Phase II

Phase IV

Phase III: 8 Phase II: 3 Phase IV: 10

Oversight events:

1 serious breach 1 unexpected event across 1 trial

View oversight register →

Indications tested

B-cell lymphoma 1 Spinal cord injury 1 Implant site infection 1

Sponsors using this IMP

Assistance Publique Hopitaux De Paris 3 Turku University Hospital 3 Centre Hospitalier Universitaire De Nantes 2 Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla 2 Gentofte Hospital 2 Fondazione Gimema Franco Mandelli Onlus 1 Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca 1 Hvidovre Hospital 1 Leiden University Medical Center 1 Pirkanmaan hyvinvointialue 1 Region Midtjylland 1 Universitair Medisch Centrum Utrecht 1

All trials

21 total

Local Antibiotic Delivery for Community Acquired Pneumonia (LANDCAP 2) Pending

2024-511420-13-00 Phase II 1 country Gentofte Hospital
ANTIBIOBONTA - Assessment of the interest of a peri-operative antibiotic strategy applied to patients with asymptomatic bacteriuria undergoi… Pending

2024-515107-19-00 Phase III 1 country Centre Hospitalier Universitaire De Lille
Rifampin-free regimen versus rifampin-containing regimen in the treatment of staphylococcal prosthetic valve endocarditis: a multicenter ran… Pending

2024-518018-22-00 Phase III 1 country Centre Hospitalier Universitaire De Nantes
Optimizing the antibiotic treatment of uncomplicated acute appendicitis - APPAC II Pending

2024-518984-36-00 Phase IV 1 country Turku University Hospital
Acute appendicitis and microbiota – etiology and effects of the antimicrobial treatment - MAPPAC Pending

2024-519392-26-00 Phase IV 1 country Turku University Hospital
Antibiotic therapy vs. placebo in the treatment of acute uncomplicated appendicitis: a prospective randomized double-blind placebo-controlle… Pending

2025-520761-44-00 Phase IV 1 country Turku University Hospital
PREV-CART - “A multicentric phase III randomized clinical trial open-label, comparing immunoglobulin replacement therapy (IgRT) and antibiot… Pending

2025-521571-30-00 Phase III 1 country Assistance Publique Hopitaux De Paris
Phase IV, randomized, open label, parallel groups clinical trial for evaluating the early Stop of antibiotic Treatment in high-risk febrile … Pending

2025-524264-38-00 Phase IV 1 country Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca
LIBRETTO: Stimulan™ Local Antibiotic Delivery System Versus 4-Week Systemic Antibiotic Therapy for Diabetic Foot Osteomyelitis – A Prospecti… Pending

2025-524723-52-00 Phase III 1 country Pirkanmaan hyvinvointialue
Efficacy and safety of 7 versus 14 days of antibiotic treatment for bacteremia produced by Pseudomonas aeruginosa: a multicenter, randomized… Recruiting

2023-508441-41-00 Phase IV 1 country Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevil…
Rapid Oral Switch in Infectious Endocarditis, the ROSIE study Recruiting

2025-524484-20-00 Phase IV 1 country UZ Leuven
The DALBA-study Introduction of the antibiotic dalbavancin in orthopaedic surgery – an evaluation of: • Health economic costs • Patient-repo… Recruiting

2025-522088-13-00 Phase IV 1 country Region Midtjylland
Local Antibiotic Delivery for Community Acquired Pneumonia - Pilot study (LANDCAP1) Recruiting

2024-511413-37-00 Phase II 1 country Gentofte Hospital
Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia: A randomized, non-blinded, no… Recruiting

2024-519186-21-01 Phase IV 1 country Hvidovre Hospital
Efficacy and safety of different antimicrobial DURATions for the treatment of Infections associated with Osteosynthesis Material implanted a… Recruiting

2023-508442-18-00 Phase III 1 country Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevil…
CUSTOMIZED ANTIBIOTIC TREATMENT DURATION AMONG HOSPITALIZED PATIENTS WITH MODERATELY SEVERE COMMUNITY-ACQUIRED PNEUMONIA [CAT-CAP] Recruiting

2023-504208-27-00 Phase III 1 country Assistance Publique Hopitaux De Paris
Staphylococcus aureus Network Adaptive Platform trial (SNAP) Recruiting

2023-503582-35-00 Phase IV 4 countries University Medical Center Utrecht
The RiCOTTA study: Rifampicin Combination Therapy versus Targeted Antibiotic Monotherapy for Infected Joint Prostheses Caused by Staphylococ… Recruiting

2022-501620-26-00 Phase IV 1 country Leiden University Medical Center
Study to treat adult patients with Very High-Risk T-cell Acute Lymphoblastic Leukemia (ALL) with Daratumumab in addition to the National ALL… Ended

2024-511627-34-00 Phase II 1 country Fondazione Gimema Franco Mandelli Onlus
Randomized, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia (REMAP-CAP) Ended

2023-507889-89-00 Phase III 13 countries Universitair Medisch Centrum Utrecht
COTRIVAP - Efficacy of cotrimoxazole as a de-escalation treatment of Ventilator-Associated Pneumonia in intensive care unit Ended

2023-505108-52-00 Phase III 1 country Assistance Publique Hopitaux De Paris

Showing 1–21 of 21 trials

← All drugs A–Z